We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Share Name | Share Symbol | Market | Type | Share ISIN | Share Description |
---|---|---|---|---|---|
Hikma Pharmaceuticals Plc | LSE:HIK | London | Ordinary Share | GB00B0LCW083 | ORD SHS 10P |
Price Change | % Change | Share Price | Bid Price | Offer Price | High Price | Low Price | Open Price | Shares Traded | Last Trade | |
---|---|---|---|---|---|---|---|---|---|---|
-20.00 | -1.02% | 1,934.00 | 1,925.00 | 1,926.00 | 1,956.00 | 1,919.00 | 1,955.00 | 145,039 | 16:35:28 |
Industry Sector | Turnover | Profit | EPS - Basic | PE Ratio | Market Cap |
---|---|---|---|---|---|
Pharmaceutical Preparations | 2.88B | 192M | 0.8653 | 22.25 | 4.34B |
Hikma Pharmaceuticals PLC
Director Declaration
In accordance with Listing Rule 9.6.14, Hikma Pharmaceuticals PLC announces that Victoria Hull, Senior Independent Non-Executive Director, has been appointed as a Non-Executive Director of Serco Group PLC with effect from 1 September 2024.
- ENDS -
Enquiries:
Hikma Pharmaceuticals PLC |
|
Helen Middlemist Group Company Secretary |
+44 20 7399 2760 |
1 Year Hikma Pharmaceuticals Chart |
1 Month Hikma Pharmaceuticals Chart |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions